The effects on the inflammatory axis of IL-23/Th17 cells in the mice model of experimental autoimmune encephalomyelitis mediated by exogenous transforming growth factor β1
Huang Guo
Abstract
Huang Guo
Abstract
Objective:To investigate the variation of IL-23/Th17 axis in the model mice of experimental autoimmune encephalomyelitis administered with exogenous transforming growth factor β1 for its possible pathogenesis.Methods:The C57BL/6 mice were immunized with MOG35-55 to establish the animal model of EAE,which was treated with TGF-β1 after immunization at multiple time points,and the expression of IL-23,IL-17 and IL-6 was analyzed by RT-PCR and ELISA.Results:Compared to those of the EAE group,the expressions of IL-23,IL-17 and IL-6 were all increased significantly at the onset(P0.05,P0.05,P0.05);And at the peak,the expression of IL-23 was down-regulated(P0.05) while the expressions of both IL-17 and IL-6 were still high(P0.05,P0.05);And during the chronic phase,it was found that there was low expression of IL-23 and IL-17(P0.05,P0.05),and the high expression of IL-6(P0.05).Conclusion:The exogenous TGF-β1 on EAE may up-regulate the expression of IL-23 and IL-17 to accelerate the progress of EAE and increase the symptom at the peak,while down-regulating their expression to ameliorate the symptom during the chronic phase.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To investigate the variation of IL-23/Th17 axis in the model mice of experimental autoimmune encephalomyelitis administered with exogenous transforming growth factor β1 for its possible pathogenesis.Methods:The C57BL/6 mice were immunized with MOG35-55 to establish the animal model of EAE,which was treated with TGF-β1 after immunization at multiple time points,and the expression of IL-23,IL-17 and IL-6 was analyzed by RT-PCR and ELISA.Results:Compared to those of the EAE group,the expressions of IL-23,IL-17 and IL-6 were all increased significantly at the onset(P0.05,P0.05,P0.05);And at the peak,the expression of IL-23 was down-regulated(P0.05) while the expressions of both IL-17 and IL-6 were still high(P0.05,P0.05);And during the chronic phase,it was found that there was low expression of IL-23 and IL-17(P0.05,P0.05),and the high expression of IL-6(P0.05).Conclusion:The exogenous TGF-β1 on EAE may up-regulate the expression of IL-23 and IL-17 to accelerate the progress of EAE and increase the symptom at the peak,while down-regulating their expression to ameliorate the symptom during the chronic phase.
Key concepts: Experimental autoimmune encephalomyelitis, Interleukin 17, Transforming growth factor, Pathogenesis, Immunology, Interleukin 23, Encephalomyelitis, Medicine